Mallinckrodt sells Intrathecal Therapy business in $203 million deal
Jan 30, 2017, 6:39am CST
Mallinckrodt president and CEO, said the deal is part of the company's effort to transform its portfolio by divesting non-core businesses and growing its platforms in autoimmune and rare diseases and hospital therapies.
http://www.bizjournals.com/stlouis/...intrathecal-therapybusiness-in.html?ana=yahoo
IMO - these guys don't appear to mess around...from my perspective they have timetable and a program.
Please DYOR ..fascinating times ahead.
- Forums
- ASX - By Stock
- Mallinckrodt
Mallinckrodt sells Intrathecal Therapy business in $203 million...
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.15 |
Change
0.025(2.22%) |
Mkt cap ! $1.313B |
Open | High | Low | Value | Volume |
$1.16 | $1.19 | $1.14 | $5.574M | 4.806M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 52625 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.15 | 21666 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 43713 | 1.145 |
21 | 199168 | 1.140 |
14 | 226537 | 1.135 |
15 | 125998 | 1.130 |
4 | 432022 | 1.125 |
Price($) | Vol. | No. |
---|---|---|
1.150 | 18739 | 15 |
1.155 | 72042 | 14 |
1.160 | 119123 | 15 |
1.165 | 128556 | 17 |
1.170 | 160167 | 18 |
Last trade - 13.33pm 22/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.15 |
  |
Change
0.025 ( 2.91 %) |
|||
Open | High | Low | Volume | ||
$1.16 | $1.19 | $1.14 | 708577 | ||
Last updated 13.54pm 22/05/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RDN
RAIDEN RESOURCES LIMITED
Dusko Ljubojevic, MD
Dusko Ljubojevic
MD
SPONSORED BY The Market Online